HYPR hyperfine.io: Forward P/S Multiple

Graphic logo of Hyperfine Corp (HYPR)

The deployment of mobile MRI units in clinics generates a steady stream of service payments, and the projected P/S of Hyperfine, Inc. (HYPR) reflects this trend, with the latest value recorded as 3.30. The Swoop system has streamlined bedside patient examinations while reducing costs. Patent protection of this unique niche creates a robust barrier, although the current scale of expansion remains moderate.

hyperfine.io - HYPR Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Hyperfine Medical (HYPR)

- current price and projected stock value:
Stock Price Hyperfine|HYPR - Average Forecast Price
- company stock capitalization data:
Market Capitalization Hyperfine Medical|HYPR - Business Value
- issuer book value statistics:
Book Value per Share Hyperfine|HYPR - Book Valuation of Business|Market Capitalization to Book Value Ratio hyperfine.io|HYPR - Cumulative Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Hyperfine, Inc.|HYPR - Long-Term Debt to Capital|Short-Term Debt to Equity Hyperfine, Inc.|HYPR - Company Debts|Debt to Book Value Hyperfine Medical|HYPR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Hyperfine|Quick Liquidity hyperfine.io
- financial results and valuation multiples details:
HYPR - Annual Net Income|Future Profit Hyperfine, Inc.|HYPR - P/E Multiple|Forward P/E Multiple Hyperfine Corp|HYPR - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Hyperfine Medical|HYPR - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Hyperfine|HYPR - Net earnings per share for the last 12 months|Quarterly EPS earnings growth hyperfine.io|HYPR - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Hyperfine, Inc.
- sales volume and revenue indicators:
HYPR - Company Sales Volume|Company Future Sales Volume Hyperfine|HYPR - Market Cap to Sales Volume|Forward P/S Multiple Hyperfine Medical
Summary company analytics:Hyperfine (HYPR)
Product sample of Hyperfine, Inc.

Hyperfine, Inc. (HYPR) commercializes innovative Swoop portable MRI systems, establishing its status as a growing medical business. The forward P/S ratio compares the company's current market value with projected revenue, allowing investors to assess whether the premium for future growth is justified and to identify signs of asset overvaluation by analyzing the trend on this chart.

Key competitors

Forward P/S Multiple ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Market Cap to Future Revenue Ratio|GE Healthcare Corp - Forward P/S Multiple|MTD (Mettler Toledo Inc) - Market Cap to Projected Revenue|WAT: Forward P/S Multiple|TECH - Market Cap to Expected Sales Ratio|BRKR (Bruker) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Azenta Inc (AZTA)|Forward P/S Multiple VREX|Forward P/S Multiple Semler (SMLR)|Price-to-Projected Revenue Ratio Butterfly Network, Inc. BFLY|mesalabs.com - Price-to-Projected Revenue Ratio|QSI: Forward Price-to-Revenue Multiple|Forward Price to Sales NNOX (Nano-X Imaging)|QTRX: Forward P/S Multiple|Market Cap to Future Revenue Ratio 908 Devices Corporation (MASS)|Price-to-Projected Revenue Ratio CapsoVision, Inc.|MXCT - Projected Price to Revenue|Forward Price-to-Revenue Multiple RPID (Rapid Micro Biosystems)|Forward P/S Multiple Seer Inc (SEER)|Forward P/S Multiple FONR (FONAR Corp)|Market Cap to Expected Sales Ratio Daxor Corp (DXR)|MDAI - Price-to-Projected Revenue Ratio|Future Price to Revenue VIVS|Aclarion, Inc. (ACON) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Talis Biomedical Corp TLIS|Price-to-Projected Revenue Ratio T2 Biosystems, Inc. (TTOO)